Clinical trial
Study NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NCT05620693 is registered in ClinicalTrials.gov with Shenzhen University General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
- Lead sponsor
- Shenzhen University General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 11, 2022
- Completion date
- December 1, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced soft-tissue sarcoma